1. Home
  2. covid 19

NIH clinical trial of investigational vaccine for COVID-19 begins

$ 13.99

4.7 (761) In stock

Study enrolling Seattle-based healthy adult volunteers.

US begins clinical trial of coronavirus vaccine

In the News National Institutes of Health (NIH)

National Institutes of Health (NIH) - Launched in record speed, #NIH started enrollment for a Phase 1 #clinicaltrial of an investigational vaccine for # COVID19 for healthy adults in the Seattle area. .gov/news-events/news-releases/nih

Stages in COVID-19 vaccine development: The Nemesis, the Hubris and the Elpis

Frontiers COVID-19: Emergence, Spread, Possible Treatments, and Global Burden

A Flurry of COVID-19 Studies Are Underway, but Scientists Warn a Vaccine Will Take Time

COVID-19 mitigation: nanotechnological intervention, perspective, and future scope - Materials Advances (RSC Publishing) DOI:10.1039/D2MA00797E

NIH on X: A Phase 3 clinical trial of investigational vaccine mRNA-1273 to prevent #COVID19, co-developed by #NIH @NIAIDNews and @Moderna, has begun. The multisite trial will assess preventive power, enrolling 30k+

COVID-19 Prevention Clinical Studies Seek Volunteers

Global trial to test whether MMR vaccine protects front-line health-care workers against COVID-19 – Washington University School of Medicine in St. Louis